BDBM50339922 CHEMBL1761658::trans-rac-2-(1-(2-(7-chloro-5-(2-chlorophenyl)-1-isobutyl-2-oxo-4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)acetyl)piperidin-4-yl)acetic acid
SMILES: CC(C)C[C@@H]1c2ccc(Cl)cc2[C@H](CN(CC(=O)N2CCC(CC(O)=O)CC2)C1=O)c1ccccc1Cl
InChI Key: InChIKey=SJYICAYPBJXIFV-JWQCQUIFSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Squalene synthetase (Homo sapiens (Human)) | BDBM50339922 (CHEMBL1761658 | trans-rac-2-(1-(2-(7-chloro-5-(2-c...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma AG Curated by ChEMBL | Assay Description Inhibition of squalene synthase assessed as conversion of [3H]farnesyl phosphate to [3H]squalene after 10 mins by scintillation counting | Bioorg Med Chem Lett 21: 2554-8 (2011) Article DOI: 10.1016/j.bmcl.2011.02.004 BindingDB Entry DOI: 10.7270/Q22Z15VJ | |||||||||||
More data for this Ligand-Target Pair |